Patents Assigned to ENDODIAG
  • USE OF THE CD71 RECEPTOR IN THE PROGNOSIS AND TREATMENT OF ENDOMETRIOSIS
    Publication number: 20190352415
    Abstract: The CD71 receptor is used as a target in the prognosis and/or treatment of endometriosis, and to a test for the prognosis or therapeutic monitoring of endometriosis, targeting this receptor.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 21, 2019
    Applicants: ENDODIAG, INATHERYS
    Inventors: Pierre LAUNAY, Coralie BELANGER, Cécile REAL